Analyst Insights

Reviews, Opinions, Statistics and Insights of Global Healthcare Markets covering Animal Healthcare, Biotechnology, Clinical Diagnostics, Healthcare IT, Healthcare Services, Medical Devices, Medical Equipment, and Pharmaceuticals.

EU5 (Germany, France, UK, Italy, Spain) In Vitro Diagnostics Market

In vitro diagnostics (IVDs) are non-invasive tests performed on biological samples (for example blood, urine or tissues) to diagnose or exclude a disease. IVDs provide valuable information about how the body is functioning and the state of health. They are used for diagnosis, screening and therapeutic monitoring of diseases. IVDs have a broad scope ranging from sophisticated technologies performed in clinical laboratories to simple self-tests, such as those for pregnancy and glucose monitoring. In vitro diagnostics are an essential part of today’s healthcare. IVDs are used to diagnose, monitor, screen and assess predispositions to diseases, thereby contributing to the available medical information regarding a patient. By allowing earlier and more targeted treatments, IVDs help to reduce hospitals stays and convalescences, resulting in a healthier population, reduced costs and economic growth [...]

2017-11-05T22:53:03+00:00 Categories: Analyst Insights|

Global Medical Equipment Providers – Market Share Forecast 2018-2020

The global market share % forecast (2018-2020) of major medical equipment or medical device providers for diagnostic equipment, biopsy devices, cardiology devices, ophthalmology equipment, and in-vitro diagnostic devices would be as follows: Global Diagnostic Imaging Equipment Providers Major Players Market Share Siemens Healthcare 27.3% General Electric Healthcare 25.5% Phillips Healthcare 13.6% Toshiba Healthcare 12.8% Carestream Healthcare 5.5% Others 15.3%   Global Biopsy Device (Oncology and Urology) Equipment Providers Major Players Market Share C. R. Bard 27% Devicor Medical Products 25% Care Fusion Corp. 22% Hologic Corp. 16% Others 10%   Global Cardiology Equipment Providers Major Players Market Share Medtronic 22.4% Boston Scientific 10.5% St. Jude Medical 12.2% Abbott Laboratories 7.6% Edwards Lifesciences 7.8% Others 39.5   Global Ophthalmic Equipment Providers Major Players Market Share Novartis 27.5% Essilor International 26.8% Johnson [...]

2017-11-04T09:36:39+00:00 Categories: Analyst Insights|

Anti-Aging Research, Products, Services and Marketplace

The science of Anti-Aging and Aesthetic Medicine is multidisciplinary with advances in the fields of biochemistry, biology, and physiology. Anti-aging medicine addresses antioxidant defense, neuroendocrine orchestration, genetic control of aging, a nutritional plan and supplementation, lifestyle modification, anti-aging medicines, and assessing and monitoring the biomarkers associated with aging. While the global population is aging at an unprecedented rate, Anti-Aging and Aesthetic Medicine has been developed as a healthcare concept offering solutions to extend the healthy lifespan of individuals. Many symptoms associated with aging resemble those of true hormone deficiency in young adults. Since appropriate hormone replacement therapy has proven beneficial for hormone-deficient patients, and given the fact that aging has been associated with decreasing hormonal levels, hormone replacement of healthy elderly subjects has become increasingly popular in anti-aging medicine. However, [...]

2017-02-24T12:37:59+00:00 Categories: Analyst Insights|

Healthcare IT Industry Landscape: Market Segments, Drivers, and Trends Analysis

The Healthcare IT industry is booming. Over the recent years, many companies have had robust growth and the sector has attracted huge inflow of private and public investments. There are many types of Healthcare information technology (HCIT) companies, operating with different business models and participating in various segments of the industry. HCIT industry is more likely to favor large companies with broad capabilities, as the consolidations remains strong. Market Segments of Healthcare IT Industry: Healthcare information technology is a broad term that covers a variety of products and services. From a product function perspective, HCIT includes electronic health/medical records (EHR or EMR), financial solutions for providers such as revenue cycle management (RCM) and practice management (PM), data integration and interchangeability solutions such as health information exchange (HIE), Population health/data analytics, [...]

2017-11-03T11:12:53+00:00 Categories: Analyst Insights|

Therapeutic Monoclonal Antibodies: Global Markets, Dynamics, and Forecast

Monoclonal antibodies (mAbs) currently represent the largest class of biopharmaceutical products. With the approval of chimeric monoclonal antibody products, followed by the approval of humanized and then fully human monoclonal antibodies, the rate of product approvals and sales of monoclonal antibody products has increased dramatically.  The number of monoclonal antibody products approved for commercial sale in the US and Europe has grown steadily, with average three to five new products are approved per year for the last several years. Out of the total monoclonal antibody products approved and marketed in the United States and Europe, only about 5% are produced in E. coli, while all of the other products are produced in mammalian cells. Genetically-engineered mice now act as robust engines for the generation of diverse repertoires of affinity-matured, fully-human [...]

2017-01-27T12:29:21+00:00 Categories: Analyst Insights|

European Pharmaceutical Industry: Recent Trends and Statistics

The research based pharmaceutical industry in Europe is entering an exciting new era in medicines development and the industry can play a critical role in restoring Europe to growth and ensuring future competitiveness in an advancing global economy. Some major steps in biopharmaceutical research, complimented by many smaller steps, have allowed for reductions in mortality, for instance from HIV/ AIDS–related causes and a number of cancers. High blood pressure and cardiovascular disease can be controlled with antihypertensive and cholesterol lowering medicines; knee or hip replacements prevent patients from immobility; and some cancers can be controlled – or even cured – with the help of new targeted treatments. Yet, major hurdles remain, including Alzheimer’s, Multiple Sclerosis, many cancers, and orphan diseases. The major disease areas in Europe includes Diseases of the [...]

2017-11-03T10:50:33+00:00 Categories: Analyst Insights|

Worldwide Primary Immunodeficiency Statistics: Patients, Trends, Market

Primary immunodeficiencies (PI) are defects of the immune system that cause severe, sometimes life threatening, infections if not diagnosed and treated appropriately. Many patients with PI are undiagnosed, underdiagnosed, or misdiagnosed. There are at least 300 genetically defined single-gene inborn errors of immunity. Recent studies have shown that PI may be more common than previously estimated and that as many as 1–2% of the population may be affected with a PI when all types and varieties are considered. Over the last decade, improvements in molecular diagnosis, genetic sequencing, and cutting edge research and treatments have led to a better understanding of the immune system, as well as improved quality of life for those living with PI. However, awareness of PI among physicians and the general public remains challenging, and there [...]

2017-01-02T11:57:02+00:00 Categories: Analyst Insights|
Load More Posts